We treated four different ESCC cell lines by CUDC-907 with doses ranging from 5 to 50 nM for 24 h and observed increased concentration-dependent apoptosis activity with Annexin V/PI assay (Fig. 2c, Additional file 1: Fig. S2b). Here, ANXA5 is linked to esophageal squamous cell carcinoma.